Markel Co. (NYSE:MKL) Shares Sold by Aviva PLC

Aviva PLC reduced its holdings in shares of Markel Co. (NYSE:MKL – Get Rating) by 17.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,058 shares of the insurance provider’s stock after selling 627 shares during the quarter. Aviva PLC’s holdings in Markel were worth $21,642,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC boosted its position in shares of Markel by 120.0% during the 3rd quarter. Global Retirement Partners LLC now owns 22 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 12 shares in the last quarter. Belpointe Asset Management LLC acquired a new position in shares of Markel during the 4th quarter worth about $30,000. U.S. Capital Wealth Advisors LLC acquired a new position in shares of Markel during the 4th quarter worth about $33,000. Achmea Investment Management B.V. acquired a new position in shares of Markel during the 1st quarter worth about $41,000. Finally, Ronald Blue Trust Inc. lifted its holdings in shares of Markel by 87.5% in the 4th quarter. Ronald Blue Trust Inc. now owns 30 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 14 shares during the last quarter. 75.96% of the stock is owned by institutional investors and hedge funds.

Markel Stock Down 0.3 %

Markel stock opened at $1,313.95 on Friday. The stock has a 50-day simple moving average of $1,315.49 and a 200-day simple moving average of $1,320.57. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.66 and a current ratio of 0.66. The company has a market capitalization of $17.54 billion, a P/E ratio of 63.72 and a beta of 0.78. Markel Co. has a fifty-two week low of $1,064.09 and a fifty-two week high of $1,458.56.

Insider Buying and Selling at Markel

In related news, Director A. Lynne Puckett acquired 75 shares of Markel stock in a transaction on Friday, April 28th. The stock was purchased at an average cost of $1,340.66 per share, with a total value of $100,549.50. Following the purchase, the director now directly owns 1,031 shares in the company, valued at $1,382,220.46. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director A. Lynne Puckett acquired 75 shares of Markel stock in a transaction on Friday, April 28th. The stock was purchased at an average cost of $1,340.66 per share, with a total value of $100,549.50. Following the purchase, the director now directly owns 1,031 shares in the company, valued at $1,382,220.46. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Morgan E. Housel acquired 19 shares of Markel stock in a transaction on Thursday, May 4th. The shares were bought at an average cost of $1,330.70 per share, with a total value of $25,283.30. Following the completion of the purchase, the director now owns 330 shares in the company, valued at $439,131. The disclosure for this purchase can be found here. Insiders purchased a total of 194 shares of company stock valued at $260,642 in the last ninety days. Insiders own 1.75% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on MKL shares. Truist Financial boosted their target price on Markel from $1,300.00 to $1,400.00 and gave the company a “hold” rating in a report on Friday, February 3rd. StockNews.com raised Markel from a “hold” rating to a “buy” rating in a report on Friday, May 19th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $1,516.67.

Markel Company Profile

(Get Rating)

Markel Corp. is a financial holding company, which engages in underwriting specialty insurance products for a variety of niche markets. It operates through the Insurance and Reinsurance segments. The Insurance segment includes all direct business and facultative placements written within the company’s underwriting operations.